COVID-19 and the heart: insights from the National Societies of Cardiology Journals.
作者信息
Monsuez Jean-Jacques
机构信息
Hôpital René Muret, Hôpitaux Universitaires de Paris Seine Saint-Denis, Avenue du docteur Schaeffner, Sevran 93270, France.
出版信息
Eur Heart J. 2021 Oct 14;42(39):4003-4005. doi: 10.1093/eurheartj/ehab262.
Abstract
摘要
相似文献
1
COVID-19 and the heart: insights from the National Societies of Cardiology Journals.新冠病毒与心脏：来自各国心脏病学学会期刊的见解
Eur Heart J. 2021 Oct 14;42(39):4003-4005. doi: 10.1093/eurheartj/ehab262.
2
[Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals].[欧洲心脏病学会各国心血管杂志的利益冲突政策与披露要求]
Arch Cardiol Mex. 2012 Apr-Jun;82(2):170-80.
3
Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.欧洲心脏病学会各国家心血管杂志的利益冲突政策及披露要求
Rev Esp Cardiol (Engl Ed). 2012 May;65(5):471-8. doi: 10.1016/j.recesp.2012.02.002. Epub 2012 Mar 30.
4
Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.欧洲心脏病学会各国家心血管杂志的利益冲突政策及披露要求
Rev Port Cardiol. 2012 Apr;31(4):329-36. doi: 10.1016/j.repc.2011.12.014.
5
Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.欧洲心脏病学会国家心血管期刊的利益冲突政策和披露要求。
Eur Heart J. 2012 Mar;33(5):587-94. doi: 10.1093/eurheartj/ehr464.
6
[Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals].[欧洲心脏病学会各国心血管杂志的利益冲突政策与披露要求]
G Ital Cardiol (Rome). 2012 Apr;13(4):236-43. doi: 10.1714/1056.11555.
7
Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.欧洲心脏病学会国家心血管期刊的利益冲突政策和披露要求。
Arq Bras Cardiol. 2012 Jun;98(6):471-9.
8
Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.欧洲心脏病学会国家心血管期刊的利益冲突政策和披露要求。
Circ J. 2012;76(7):1542-9. doi: 10.1253/circj.cj-66-0045. Epub 2012 May 24.
9
Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.欧洲心脏病学会国家心血管期刊的利益冲突政策和披露要求。
Neth Heart J. 2012 Jun;20(6):279-87. doi: 10.1007/s12471-012-0277-7.
10
Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals.欧洲心脏病学会国家心血管期刊的利益冲突政策和披露要求。
Hellenic J Cardiol. 2012 May-Jun;53(3):179-88.
引用本文的文献
1
Scientific Basics of Personalized Medicine: Realities and Opportunities.个性化医疗的科学基础：现实与机遇
Her Russ Acad Sci. 2022;92(6):671-682. doi: 10.1134/S1019331622060041. Epub 2023 Jan 31.
2
[Acute coronary syndromes and COVID-19: An informative imbalance].[急性冠状动脉综合征与新型冠状病毒肺炎：信息失衡]
Arch Mal Coeur Vaiss Pratique. 2022 Nov;2022(312):16-18. doi: 10.1016/j.amcp.2022.09.009. Epub 2022 Sep 27.
本文引用的文献
1
Cardiac arrhythmias in patients presenting with COVID-19 treated in Portuguese hospitals: A national registry from the Portuguese Association of Arrhythmology, Pacing and Electrophysiology.葡萄牙心律失常学、起搏和电生理学协会的全国登记处：葡萄牙医院治疗的 COVID-19 患者的心律失常。
Rev Port Cardiol (Engl Ed). 2021 Aug;40(8):573-580. doi: 10.1016/j.repce.2020.11.025.
2
Scientific publication activity during COVID-19 shutdown.新冠疫情封锁期间的科研出版活动。
Clin Res Cardiol. 2020 Dec;109(12):1443-1445. doi: 10.1007/s00392-020-01707-9.
3
The 2020 research pandemic: A bibliometric analysis of publications on COVID-19 and their scientific impact during the first months.2020 年研究大流行：COVID-19 相关出版物及其在最初几个月的科学影响力的文献计量分析。
Arch Cardiol Mex. 2021 Dec 20;91(Suplemento COVID):001-011. doi: 10.24875/ACM.20000370.
4
An optimal chest compression technique using personal protective equipment during resuscitation in the COVID-19 pandemic: a randomized crossover simulation study.在 COVID-19 大流行期间使用个人防护设备进行复苏时的最佳胸部按压技术：一项随机交叉模拟研究。
Kardiol Pol. 2020 Dec 23;78(12):1254-1261. doi: 10.33963/KP.15643. Epub 2020 Oct 12.
5
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience.新型冠状病毒肺炎对ST段抬高型心肌梗死治疗的影响。西班牙的经验。
Rev Esp Cardiol (Engl Ed). 2020 Dec;73(12):994-1002. doi: 10.1016/j.rec.2020.08.002. Epub 2020 Sep 8.
6
Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool.2019冠状病毒病中的心血管疾病：对10898例患者的系统评价和荟萃分析以及一种分诊风险分层工具的建议
Egypt Heart J. 2020 Jul 13;72(1):41. doi: 10.1186/s43044-020-00075-z.
7
Evaluation and follow-up of pediatric COVID-19 in terms of cardiac involvement: A scientific statement from the Association of Turkish Pediatric Cardiology and Pediatric Cardiac Surgery.儿童新冠病毒病心脏受累情况的评估与随访：土耳其儿科心脏病学与儿科心脏外科学会的科学声明
Anatol J Cardiol. 2020 Jul;24(1):13-18. doi: 10.14744/AnatolJCardiol.2020.36559.
8
Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system.临床用于治疗新型冠状病毒肺炎（Sars-cov 2/冠状病毒-19）的中医疗法及其对心血管系统的影响。
Turk Kardiyol Dern Ars. 2020 Jun;48(4):410-424. doi: 10.5543/tkda.2020.03374.
9
Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series.同种异体心脏球源性细胞（CAP-1002）治疗危重症 COVID-19 患者：同情使用病例系列。
Basic Res Cardiol. 2020 May 12;115(4):36. doi: 10.1007/s00395-020-0795-1.
10
One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic.一种疾病可能掩盖另一种疾病：由于 COVID-19 大流行，急性心血管疾病可能被忽视。
Arch Cardiovasc Dis. 2020 May;113(5):303-307. doi: 10.1016/j.acvd.2020.04.002. Epub 2020 Apr 28.
Zotero 插件